P
Pierre Ernst
Researcher at McGill University
Publications - 241
Citations - 17884
Pierre Ernst is an academic researcher from McGill University. The author has contributed to research in topics: Asthma & COPD. The author has an hindex of 64, co-authored 232 publications receiving 16614 citations. Previous affiliations of Pierre Ernst include Jewish General Hospital & McGill University Health Centre.
Papers
More filters
Journal Article
The pharmacoepidemiology of COPD: recent advances and methodological discussion.
P Burney,Samy Suissa,Joan B. Soriano,William M. Vollmer,Giovanni Viegi,Sean D. Sullivan,Leonardo M. Fabbri,Don D. Sin,Pierre Ernst,D Coultas,Jean Bourbeau,Douglas W. Mapel,Klaudiusz R. Weiss,T McLaughlin,David Price,M C J M Sturkenboom,Rod S Taylor,G W Hagan +17 more
Journal ArticleDOI
Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice.
TL;DR: In this paper, the authors compared the effectiveness and safety of triple therapy with a LAMA-LABA combination in a real-world clinical practice setting, and found that the triple combination of LAMA, LABA, and ICS inhalers is generally as effective as combining LAMA and LABA inhalers in preventing COPD exacerbations.
Journal ArticleDOI
The Asthma Quiz for Kidz: a validated tool to appreciate the level of asthma control in children.
TL;DR: The Asthma Quiz score provides complementary information to, but does not replace, lung function testing and should prompt patients to consult their physician for reassessment.
Journal ArticleDOI
Long-Acting Bronchodilator Initiation in COPD and the Risk of Adverse Cardiopulmonary Events: A Population-Based Comparative Safety Study.
TL;DR: COPD treatment initiation with tiotropium compared with LABA does not increase cardiovascular risk in the first year of treatment, and the risk of pneumonia is higher withLABA, a likely effect of the inhaled corticosteroids present in many LABA inhalers used in real world clinical practice.
Journal ArticleDOI
Pneumonia risk in asthma patients using inhaled corticosteroids: a quasi-cohort study.
Christina J. Qian,Christina J. Qian,Janie Coulombe,Samy Suissa,Samy Suissa,Pierre Ernst,Pierre Ernst +6 more
TL;DR: ICS use in asthma patients appears to be associated with an increased risk of pneumonia and is present for both budesonide and fluticasone.